<p>虽然上周没有传统的首次公开募股（IPO），但有三家空白支票公司定价，并且几笔大额交易加入了管道。</p>
<p>本周的三笔空白支票 IPO 由 <strong>Inflection Point Acquisition VI</strong>（IPFXU）主导，筹集了 2.2 亿美元，目标是技术驱动的企业。</p>
<p>三家 SPAC 也提交了初步申请。<strong>Collective Acquisition II</strong>（CAIIU）计划筹集 2.2 亿美元，目标是金融、国防技术和人工智能。<strong>Oceanhawk Acquisition</strong>（OHACU）计划筹集 2 亿美元，由投资公司 OceanHawk 支持。<strong>Research Alliance III</strong>（RACC）计划筹集 5000 万美元，由 RA Capital 成立。</p>
<table>
<thead>
<tr>
<th>2026 年 3 月 23 日当周的 9 份申请</th>
</tr>
</thead>
<tbody>
<tr>
<td>发行人<br/><em>业务</em></td>
</tr>
<tr>
<td>---</td>
</tr>
<tr>
<td>Alamar Biosciences (ALMR)</td>
</tr>
<tr>
<td><em>提供用于疾病检测研究的蛋白质生物标志物检测平台。</em></td>
</tr>
<tr>
<td>Collective Acquisition II (CAIIU)</td>
</tr>
<tr>
<td><em>针对金融、国防技术和人工智能的空白支票公司。</em></td>
</tr>
<tr>
<td>Kailera Therapeutics (KLRA)</td>
</tr>
<tr>
<td><em>开发用于肥胖症的注射和口服 GLP-1 的第三阶段生物技术。</em></td>
</tr>
<tr>
<td>Yesway (YSWY)</td>
</tr>
<tr>
<td><em>在七个州拥有超过 400 个门店的便利店连锁。</em></td>
</tr>
<tr>
<td>AsiaPac AdTechinno Group (APAT)</td>
</tr>
<tr>
<td><em>总部位于香港的广告技术平台提供商。</em></td>
</tr>
<tr>
<td>Arxis (ARXS)</td>
</tr>
<tr>
<td><em>航空航天和国防电子及组件制造商。</em></td>
</tr>
<tr>
<td>Research Alliance III (RACC)</td>
</tr>
<tr>
<td><em>由 RA Capital 成立的空白支票公司，目标是药物开发和健康科技。</em></td>
</tr>
<tr>
<td>Aevex (AVEX)</td>
</tr>
<tr>
<td><em>提供军事无人机系统和服务。</em></td>
</tr>
<tr>
<td>Oceanhawk Acquisition (OHACU)</td>
</tr>
<tr>
<td><em>由投资公司 OceanHawk 支持的空白支票公司。</em></td>
</tr>
</tbody>
</table>

IPFXU

医药突破 ETF - ALPS

CYTOF

<p>2026 年 3 月 23 日这一周，尽管没有传统的首次公开募股（IPO），但航空航天和医疗保健领域的备案活动仍然非常活跃。包括 Inflection Point Acquisition VI 在内的三家空白支票公司共筹集了 2.2 亿美元，目标是技术驱动的企业。其他值得注意的备案包括 Alamar Biosciences 和 Kailera Therapeutics，均在医疗保健领域筹集了 1 亿美元。此外，多个特殊目的收购公司（SPAC），如 Collective Acquisition II 和 Oceanhawk Acquisition，也以可观的融资计划进入了管道</p>

<p>While there were no traditional IPOs this past week, three blank check companies priced, and several sizable deals joined the pipeline.</p>
<div class="lb-trans"><p>虽然上周没有传统的首次公开募股（IPO），但有三家空白支票公司定价，并且几笔大额交易加入了管道。</p>
</div><p>The week’s three blank check IPOs were led by <strong>Inflection Point Acquisition VI</strong> (IPFXU), which raised $220 million to target technology-enabled businesses.</p>
<div class="lb-trans"><p>本周的三笔空白支票 IPO 由 <strong>Inflection Point Acquisition VI</strong>（IPFXU）主导，筹集了 2.2 亿美元，目标是技术驱动的企业。</p>
</div><p>Three SPACs also submitted initial filings. <strong>Collective Acquisition II</strong> (CAIIU) plans to raise $220 million, targeting finance, defense technology, and AI. <strong>Oceanhawk Acquisition</strong> (OHACU) plans to raise $200 million, backed by investment firm OceanHawk. <strong>Research Alliance III</strong> (RACC) plans to raise $50 million, formed by RA Capital.</p>
<div class="lb-trans"><p>三家 SPAC 也提交了初步申请。<strong>Collective Acquisition II</strong>（CAIIU）计划筹集 2.2 亿美元，目标是金融、国防技术和人工智能。<strong>Oceanhawk Acquisition</strong>（OHACU）计划筹集 2 亿美元，由投资公司 OceanHawk 支持。<strong>Research Alliance III</strong>（RACC）计划筹集 5000 万美元，由 RA Capital 成立。</p>
</div><table>
<thead>
<tr>
<th>9 Filings During the Week of March 23rd, 2026</th>
</tr>
</thead>
<tbody>
<tr>
<td>Issuer<br/><em>Business</em></td>
</tr>
<tr>
<td>---</td>
</tr>
<tr>
<td>Alamar Biosciences (ALMR)</td>
</tr>
<tr>
<td><em>Provides a protein biomarker detection platform for disease detection research.</em></td>
</tr>
<tr>
<td>Collective Acquisition II (CAIIU)</td>
</tr>
<tr>
<td><em>Blank check company targeting finance, defense technology, and AI.</em></td>
</tr>
<tr>
<td>Kailera Therapeutics (KLRA)</td>
</tr>
<tr>
<td><em>Phase 3 biotech developing injectable and oral GLP-1s for obesity.</em></td>
</tr>
<tr>
<td>Yesway (YSWY)</td>
</tr>
<tr>
<td><em>Convenience store chain with over 400 locations throughout seven states.</em></td>
</tr>
<tr>
<td>AsiaPac AdTechinno Group (APAT)</td>
</tr>
<tr>
<td><em>Hong Kong-based adtech platform provider.</em></td>
</tr>
<tr>
<td>Arxis (ARXS)</td>
</tr>
<tr>
<td><em>Aerospace and defense electronics and components manufacturer.</em></td>
</tr>
<tr>
<td>Research Alliance III (RACC)</td>
</tr>
<tr>
<td><em>Blank check company formed by RA Capital targeting drug development and healthtech.</em></td>
</tr>
<tr>
<td>Aevex (AVEX)</td>
</tr>
<tr>
<td><em>Provides military unmanned aircraft systems and services.</em></td>
</tr>
<tr>
<td>Oceanhawk Acquisition (OHACU)</td>
</tr>
<tr>
<td><em>Blank check company backed by investment firm OceanHawk.</em></td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>2026 年 3 月 23 日当周的 9 份申请</th>
</tr>
</thead>
<tbody>
<tr>
<td>发行人<br/><em>业务</em></td>
</tr>
<tr>
<td>---</td>
</tr>
<tr>
<td>Alamar Biosciences (ALMR)</td>
</tr>
<tr>
<td><em>提供用于疾病检测研究的蛋白质生物标志物检测平台。</em></td>
</tr>
<tr>
<td>Collective Acquisition II (CAIIU)</td>
</tr>
<tr>
<td><em>针对金融、国防技术和人工智能的空白支票公司。</em></td>
</tr>
<tr>
<td>Kailera Therapeutics (KLRA)</td>
</tr>
<tr>
<td><em>开发用于肥胖症的注射和口服 GLP-1 的第三阶段生物技术。</em></td>
</tr>
<tr>
<td>Yesway (YSWY)</td>
</tr>
<tr>
<td><em>在七个州拥有超过 400 个门店的便利店连锁。</em></td>
</tr>
<tr>
<td>AsiaPac AdTechinno Group (APAT)</td>
</tr>
<tr>
<td><em>总部位于香港的广告技术平台提供商。</em></td>
</tr>
<tr>
<td>Arxis (ARXS)</td>
</tr>
<tr>
<td><em>航空航天和国防电子及组件制造商。</em></td>
</tr>
<tr>
<td>Research Alliance III (RACC)</td>
</tr>
<tr>
<td><em>由 RA Capital 成立的空白支票公司，目标是药物开发和健康科技。</em></td>
</tr>
<tr>
<td>Aevex (AVEX)</td>
</tr>
<tr>
<td><em>提供军事无人机系统和服务。</em></td>
</tr>
<tr>
<td>Oceanhawk Acquisition (OHACU)</td>
</tr>
<tr>
<td><em>由投资公司 OceanHawk 支持的空白支票公司。</em></td>
</tr>
</tbody>
</table>
</div>

US Weekly Recap: Aerospace and healthcare issuers drive late-March filing activity

RenaissanceCapital

Inflection Point Acquisition VI - Unit

ALTAMIRA THERAPEUTICS LTD

Aligos Therapeutics

Inflection Point  Acquisition

美国制药 ETF - iShares

Galera Therapeutics

Kalaris Therapeutics

Inflection Point Acquisition IV

Invesco Nasdaq Biotechnology ETF

纳斯达克生物科技指数 ETF - iShares Nasdaq

医疗业 ETF - SPDR

标普生物技术 3 倍做多 - Direxion

标普全球医疗股指数 ETF - iShares

医疗业 ETF - Vanguard

标普生物技术 ETF - SPDR

纽交所高增长板生物技术指数 ETF - First Trust

Karyopharm治疗

Bleichroeder Acquisition I - Unit

基因改革 ETF - ARK

MBX Biosciences

生物科技 ETF - VanEck Vectors

动态生物技术与基因组 ETF - Invesco

美国每周回顾：航空航天和医疗保健发行人推动了三月下旬的申报活动